News

• Pfizer, BioNTech grant EU 200 million vaccine doses
  11/11/2020 / 12:30 - TeleTrader
•  
• Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raises USD 8 Million Private Equity
  12/16/2019 / 09:55 - GlobeNewswire
•  
• Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS, SNS, VNS and Other CNS
  10/19/2018 / 11:00 - GlobeNewswire
•  
• Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
  01/02/2018 / 14:05 - GlobeNewswire
•  
• Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
  12/06/2017 / 16:23 - GlobeNewswire
•  
• Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
  10/19/2017 / 15:00 - GlobeNewswire
•  
• Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP 150 million
  12/02/2016 / 07:30 - GlobeNewswire
•  
• Biotech stocks continue to advance
  10/21/2016 / 07:00 - GlobeNewswire
•  
• BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
  10/11/2016 / 18:10 - GlobeNewswire
•  
• Ad hoc: BB Biotech AG with profit in the third quarter 2016
  10/11/2016 / 18:09 - GlobeNewswire
•  
• Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management to new high of close to CHF 7 bn
  07/29/2016 / 07:00 - GlobeNewswire
•  
• BB Biotech: Stabilization of biotech sector in the second quarter of 2016
  07/22/2016 / 07:01 - GlobeNewswire
•  
• BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
  07/15/2016 / 07:30 - GlobeNewswire
•  
• BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution
  07/14/2016 / 17:40 - GlobeNewswire
•  
• BB Biotech AG with after-tax loss in the first half year of 2016
  07/11/2016 / 18:10 - GlobeNewswire